Many of mine have crossed the Rubicon the last 3 years, and BIXT will be one of the next ones this year. I hear they are recruiting folks for first of two parts of the Phase III in India already, the dosing trial, to set the dose for second part of the phase III.
Lots of other catalysts brewing already.
Holy Cow who said sugar molecules were baaaahhhdASS LOL
$BIXT Galectin Antagonists (antiviral molecules) Designed by AI, and could IMO end the need for many vaccines... Already has 2 Phase III trials in two countries ready:
Viruses trigger Neurological diseases published research is out:
Market Data 
Markets 
AI
